0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Bovine Blood Plasma Derivatives - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-33N4842
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Bovine Blood Plasma Derivatives Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Bovine Blood Plasma Derivatives - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-33N4842
Report
April 2024
Pages:166
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bovine Blood Plasma Derivatives - Market Size

The global market for Bovine Blood Plasma Derivatives was estimated to be worth US$ 1919 million in 2023 and is forecast to a readjusted size of US$ 3139.9 million by 2030 with a CAGR of 7.2% during the forecast period 2024-2030

Bovine Blood Plasma Derivatives - Market

Bovine Blood Plasma Derivatives - Market

This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.
Global Bovine Blood Plasma Derivatives key players include Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), etc. Global top three manufacturers hold a share about 30%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia Pacific, both have a share over 45 percent.
In terms of product, FBS is the largest segment, with a share over 65%. And in terms of application, the largest application is Scientific Research, followed by Industrial Production, Feed, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bovine Blood Plasma Derivatives, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bovine Blood Plasma Derivatives by region & country, by Type, and by Application.
The Bovine Blood Plasma Derivatives market size, estimations, and forecasts are provided in terms of sales volume (K Liters) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Blood Plasma Derivatives.
Market Segmentation

Scope of Bovine Blood Plasma Derivatives - Market Report

Report Metric Details
Report Name Bovine Blood Plasma Derivatives - Market
Forecasted market size in 2030 US$ 3139.9 million
CAGR 7.2%
Forecasted years 2024 - 2030
Segment by Type:
  • Bovine Serum
  • FBS
  • Bovine Serum Albumin
  • Fibrinogen
  • Protein Ingredient
  • Other
Segment by Application
  • Scientific Research
  • Industrial Production
  • Feed
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals, Bovogen, Biowest, Internegocios, RMBIO, Biological Industries, VWR, Corning, Serana, Lanzhou Minhai, Zhejiang Tianhang Biotechnology, ExCell Bio, Jin Yuan Kang, American Protein Company, Sonac
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Bovine Blood Plasma Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Bovine Blood Plasma Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Bovine Blood Plasma Derivatives in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Bovine Blood Plasma Derivatives - Market size in 2030?

Ans: The Bovine Blood Plasma Derivatives - Market size in 2030 will be US$ 3139.9 million.

What is the market share of major companies in Bovine Blood Plasma Derivatives - Market?

Ans: Global top three manufacturers hold a share about 30%.

What is the Bovine Blood Plasma Derivatives - Market share by type?

Ans: In terms of product, FBS is the largest segment, with a share over 65%.

Who are the main players in the Bovine Blood Plasma Derivatives - Market report?

Ans: The main players in the Bovine Blood Plasma Derivatives - Market are Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals, Bovogen, Biowest, Internegocios, RMBIO, Biological Industries, VWR, Corning, Serana, Lanzhou Minhai, Zhejiang Tianhang Biotechnology, ExCell Bio, Jin Yuan Kang, American Protein Company, Sonac

What are the Application segmentation covered in the Bovine Blood Plasma Derivatives - Market report?

Ans: The Applications covered in the Bovine Blood Plasma Derivatives - Market report are Scientific Research, Industrial Production, Feed, Others

What are the Type segmentation covered in the Bovine Blood Plasma Derivatives - Market report?

Ans: The Types covered in the Bovine Blood Plasma Derivatives - Market report are Bovine Serum, FBS, Bovine Serum Albumin, Fibrinogen, Protein Ingredient, Other

1 Market Overview
1.1 Bovine Blood Plasma Derivatives Product Introduction
1.2 Global Bovine Blood Plasma Derivatives Market Size Forecast
1.2.1 Global Bovine Blood Plasma Derivatives Sales Value (2019-2030)
1.2.2 Global Bovine Blood Plasma Derivatives Sales Volume (2019-2030)
1.2.3 Global Bovine Blood Plasma Derivatives Sales Price (2019-2030)
1.3 Bovine Blood Plasma Derivatives Market Trends & Drivers
1.3.1 Bovine Blood Plasma Derivatives Industry Trends
1.3.2 Bovine Blood Plasma Derivatives Market Drivers & Opportunity
1.3.3 Bovine Blood Plasma Derivatives Market Challenges
1.3.4 Bovine Blood Plasma Derivatives Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bovine Blood Plasma Derivatives Players Revenue Ranking (2023)
2.2 Global Bovine Blood Plasma Derivatives Revenue by Company (2019-2024)
2.3 Global Bovine Blood Plasma Derivatives Players Sales Volume Ranking (2023)
2.4 Global Bovine Blood Plasma Derivatives Sales Volume by Company Players (2019-2024)
2.5 Global Bovine Blood Plasma Derivatives Average Price by Company (2019-2024)
2.6 Key Manufacturers Bovine Blood Plasma Derivatives Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Bovine Blood Plasma Derivatives Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bovine Blood Plasma Derivatives
2.9 Bovine Blood Plasma Derivatives Market Competitive Analysis
2.9.1 Bovine Blood Plasma Derivatives Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Bovine Blood Plasma Derivatives Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bovine Blood Plasma Derivatives as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bovine Serum
3.1.2 FBS
3.1.3 Bovine Serum Albumin
3.1.4 Fibrinogen
3.1.5 Protein Ingredient
3.1.6 Other
3.2 Global Bovine Blood Plasma Derivatives Sales Value by Type
3.2.1 Global Bovine Blood Plasma Derivatives Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bovine Blood Plasma Derivatives Sales Value, by Type (2019-2030)
3.2.3 Global Bovine Blood Plasma Derivatives Sales Value, by Type (%) (2019-2030)
3.3 Global Bovine Blood Plasma Derivatives Sales Volume by Type
3.3.1 Global Bovine Blood Plasma Derivatives Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Bovine Blood Plasma Derivatives Sales Volume, by Type (2019-2030)
3.3.3 Global Bovine Blood Plasma Derivatives Sales Volume, by Type (%) (2019-2030)
3.4 Global Bovine Blood Plasma Derivatives Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Scientific Research
4.1.2 Industrial Production
4.1.3 Feed
4.1.4 Others
4.2 Global Bovine Blood Plasma Derivatives Sales Value by Application
4.2.1 Global Bovine Blood Plasma Derivatives Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bovine Blood Plasma Derivatives Sales Value, by Application (2019-2030)
4.2.3 Global Bovine Blood Plasma Derivatives Sales Value, by Application (%) (2019-2030)
4.3 Global Bovine Blood Plasma Derivatives Sales Volume by Application
4.3.1 Global Bovine Blood Plasma Derivatives Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Bovine Blood Plasma Derivatives Sales Volume, by Application (2019-2030)
4.3.3 Global Bovine Blood Plasma Derivatives Sales Volume, by Application (%) (2019-2030)
4.4 Global Bovine Blood Plasma Derivatives Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Bovine Blood Plasma Derivatives Sales Value by Region
5.1.1 Global Bovine Blood Plasma Derivatives Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bovine Blood Plasma Derivatives Sales Value by Region (2019-2024)
5.1.3 Global Bovine Blood Plasma Derivatives Sales Value by Region (2025-2030)
5.1.4 Global Bovine Blood Plasma Derivatives Sales Value by Region (%), (2019-2030)
5.2 Global Bovine Blood Plasma Derivatives Sales Volume by Region
5.2.1 Global Bovine Blood Plasma Derivatives Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Bovine Blood Plasma Derivatives Sales Volume by Region (2019-2024)
5.2.3 Global Bovine Blood Plasma Derivatives Sales Volume by Region (2025-2030)
5.2.4 Global Bovine Blood Plasma Derivatives Sales Volume by Region (%), (2019-2030)
5.3 Global Bovine Blood Plasma Derivatives Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Bovine Blood Plasma Derivatives Sales Value, 2019-2030
5.4.2 North America Bovine Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Bovine Blood Plasma Derivatives Sales Value, 2019-2030
5.5.2 Europe Bovine Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Bovine Blood Plasma Derivatives Sales Value, 2019-2030
5.6.2 Asia Pacific Bovine Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Bovine Blood Plasma Derivatives Sales Value, 2019-2030
5.7.2 South America Bovine Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bovine Blood Plasma Derivatives Sales Value, 2019-2030
5.8.2 Middle East & Africa Bovine Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bovine Blood Plasma Derivatives Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bovine Blood Plasma Derivatives Sales Value
6.2.1 Key Countries/Regions Bovine Blood Plasma Derivatives Sales Value, 2019-2030
6.2.2 Key Countries/Regions Bovine Blood Plasma Derivatives Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Bovine Blood Plasma Derivatives Sales Value, 2019-2030
6.3.2 United States Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bovine Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bovine Blood Plasma Derivatives Sales Value, 2019-2030
6.4.2 Europe Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bovine Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bovine Blood Plasma Derivatives Sales Value, 2019-2030
6.5.2 China Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bovine Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bovine Blood Plasma Derivatives Sales Value, 2019-2030
6.6.2 Japan Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bovine Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bovine Blood Plasma Derivatives Sales Value, 2019-2030
6.7.2 South Korea Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bovine Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bovine Blood Plasma Derivatives Sales Value, 2019-2030
6.8.2 Southeast Asia Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bovine Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bovine Blood Plasma Derivatives Sales Value, 2019-2030
6.9.2 India Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bovine Blood Plasma Derivatives Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Information
7.1.2 Thermo Fisher Introduction and Business Overview
7.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Bovine Blood Plasma Derivatives Product Offerings
7.1.5 Thermo Fisher Recent Development
7.2 GE Healthcare
7.2.1 GE Healthcare Company Information
7.2.2 GE Healthcare Introduction and Business Overview
7.2.3 GE Healthcare Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GE Healthcare Bovine Blood Plasma Derivatives Product Offerings
7.2.5 GE Healthcare Recent Development
7.3 Merck (Sigma-Aldrich)
7.3.1 Merck (Sigma-Aldrich) Company Information
7.3.2 Merck (Sigma-Aldrich) Introduction and Business Overview
7.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Product Offerings
7.3.5 Merck (Sigma-Aldrich) Recent Development
7.4 Moregate BioTech
7.4.1 Moregate BioTech Company Information
7.4.2 Moregate BioTech Introduction and Business Overview
7.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Moregate BioTech Bovine Blood Plasma Derivatives Product Offerings
7.4.5 Moregate BioTech Recent Development
7.5 Gemini
7.5.1 Gemini Company Information
7.5.2 Gemini Introduction and Business Overview
7.5.3 Gemini Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Gemini Bovine Blood Plasma Derivatives Product Offerings
7.5.5 Gemini Recent Development
7.6 Atlanta Biologicals
7.6.1 Atlanta Biologicals Company Information
7.6.2 Atlanta Biologicals Introduction and Business Overview
7.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Atlanta Biologicals Bovine Blood Plasma Derivatives Product Offerings
7.6.5 Atlanta Biologicals Recent Development
7.7 Tissue Culture Biologicals
7.7.1 Tissue Culture Biologicals Company Information
7.7.2 Tissue Culture Biologicals Introduction and Business Overview
7.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Product Offerings
7.7.5 Tissue Culture Biologicals Recent Development
7.8 Bovogen
7.8.1 Bovogen Company Information
7.8.2 Bovogen Introduction and Business Overview
7.8.3 Bovogen Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bovogen Bovine Blood Plasma Derivatives Product Offerings
7.8.5 Bovogen Recent Development
7.9 Biowest
7.9.1 Biowest Company Information
7.9.2 Biowest Introduction and Business Overview
7.9.3 Biowest Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Biowest Bovine Blood Plasma Derivatives Product Offerings
7.9.5 Biowest Recent Development
7.10 Internegocios
7.10.1 Internegocios Company Information
7.10.2 Internegocios Introduction and Business Overview
7.10.3 Internegocios Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Internegocios Bovine Blood Plasma Derivatives Product Offerings
7.10.5 Internegocios Recent Development
7.11 RMBIO
7.11.1 RMBIO Company Information
7.11.2 RMBIO Introduction and Business Overview
7.11.3 RMBIO Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.11.4 RMBIO Bovine Blood Plasma Derivatives Product Offerings
7.11.5 RMBIO Recent Development
7.12 Biological Industries
7.12.1 Biological Industries Company Information
7.12.2 Biological Industries Introduction and Business Overview
7.12.3 Biological Industries Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Biological Industries Bovine Blood Plasma Derivatives Product Offerings
7.12.5 Biological Industries Recent Development
7.13 VWR
7.13.1 VWR Company Information
7.13.2 VWR Introduction and Business Overview
7.13.3 VWR Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.13.4 VWR Bovine Blood Plasma Derivatives Product Offerings
7.13.5 VWR Recent Development
7.14 Corning
7.14.1 Corning Company Information
7.14.2 Corning Introduction and Business Overview
7.14.3 Corning Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Corning Bovine Blood Plasma Derivatives Product Offerings
7.14.5 Corning Recent Development
7.15 Serana
7.15.1 Serana Company Information
7.15.2 Serana Introduction and Business Overview
7.15.3 Serana Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Serana Bovine Blood Plasma Derivatives Product Offerings
7.15.5 Serana Recent Development
7.16 Lanzhou Minhai
7.16.1 Lanzhou Minhai Company Information
7.16.2 Lanzhou Minhai Introduction and Business Overview
7.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Lanzhou Minhai Bovine Blood Plasma Derivatives Product Offerings
7.16.5 Lanzhou Minhai Recent Development
7.17 Zhejiang Tianhang Biotechnology
7.17.1 Zhejiang Tianhang Biotechnology Company Information
7.17.2 Zhejiang Tianhang Biotechnology Introduction and Business Overview
7.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Product Offerings
7.17.5 Zhejiang Tianhang Biotechnology Recent Development
7.18 ExCell Bio
7.18.1 ExCell Bio Company Information
7.18.2 ExCell Bio Introduction and Business Overview
7.18.3 ExCell Bio Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.18.4 ExCell Bio Bovine Blood Plasma Derivatives Product Offerings
7.18.5 ExCell Bio Recent Development
7.19 Jin Yuan Kang
7.19.1 Jin Yuan Kang Company Information
7.19.2 Jin Yuan Kang Introduction and Business Overview
7.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Jin Yuan Kang Bovine Blood Plasma Derivatives Product Offerings
7.19.5 Jin Yuan Kang Recent Development
7.20 American Protein Company
7.20.1 American Protein Company Company Information
7.20.2 American Protein Company Introduction and Business Overview
7.20.3 American Protein Company Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.20.4 American Protein Company Bovine Blood Plasma Derivatives Product Offerings
7.20.5 American Protein Company Recent Development
7.21 Sonac
7.21.1 Sonac Company Information
7.21.2 Sonac Introduction and Business Overview
7.21.3 Sonac Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Sonac Bovine Blood Plasma Derivatives Product Offerings
7.21.5 Sonac Recent Development
8 Industry Chain Analysis
8.1 Bovine Blood Plasma Derivatives Industrial Chain
8.2 Bovine Blood Plasma Derivatives Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bovine Blood Plasma Derivatives Sales Model
8.5.2 Sales Channel
8.5.3 Bovine Blood Plasma Derivatives Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Bovine Blood Plasma Derivatives Market Trends
    Table 2. Bovine Blood Plasma Derivatives Market Drivers & Opportunity
    Table 3. Bovine Blood Plasma Derivatives Market Challenges
    Table 4. Bovine Blood Plasma Derivatives Market Restraints
    Table 5. Global Bovine Blood Plasma Derivatives Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Bovine Blood Plasma Derivatives Revenue Market Share by Company (2019-2024)
    Table 7. Global Bovine Blood Plasma Derivatives Sales Volume by Company (2019-2024) & (K Liters)
    Table 8. Global Bovine Blood Plasma Derivatives Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Bovine Blood Plasma Derivatives Price by Company (2019-2024) & (USD/L)
    Table 10. Key Manufacturers Bovine Blood Plasma Derivatives Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Bovine Blood Plasma Derivatives Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Bovine Blood Plasma Derivatives
    Table 13. Global Bovine Blood Plasma Derivatives Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bovine Blood Plasma Derivatives as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Bovine Blood Plasma Derivatives Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Bovine Blood Plasma Derivatives Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Bovine Blood Plasma Derivatives Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Bovine Blood Plasma Derivatives Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Bovine Blood Plasma Derivatives Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Bovine Blood Plasma Derivatives Sales Volume by Type: 2019 VS 2023 VS 2030 (K Liters)
    Table 22. Global Bovine Blood Plasma Derivatives Sales Volume by Type (2019-2024) & (K Liters)
    Table 23. Global Bovine Blood Plasma Derivatives Sales Volume by Type (2025-2030) & (K Liters)
    Table 24. Global Bovine Blood Plasma Derivatives Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Bovine Blood Plasma Derivatives Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Bovine Blood Plasma Derivatives Price by Type (2019-2024) & (USD/L)
    Table 27. Global Bovine Blood Plasma Derivatives Price by Type (2025-2030) & (USD/L)
    Table 28. Global Bovine Blood Plasma Derivatives Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Bovine Blood Plasma Derivatives Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Bovine Blood Plasma Derivatives Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Bovine Blood Plasma Derivatives Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Bovine Blood Plasma Derivatives Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Bovine Blood Plasma Derivatives Sales Volume by Application: 2019 VS 2023 VS 2030 (K Liters)
    Table 34. Global Bovine Blood Plasma Derivatives Sales Volume by Application (2019-2024) & (K Liters)
    Table 35. Global Bovine Blood Plasma Derivatives Sales Volume by Application (2025-2030) & (K Liters)
    Table 36. Global Bovine Blood Plasma Derivatives Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Bovine Blood Plasma Derivatives Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Bovine Blood Plasma Derivatives Price by Application (2019-2024) & (USD/L)
    Table 39. Global Bovine Blood Plasma Derivatives Price by Application (2025-2030) & (USD/L)
    Table 40. Global Bovine Blood Plasma Derivatives Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Bovine Blood Plasma Derivatives Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Bovine Blood Plasma Derivatives Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Bovine Blood Plasma Derivatives Sales Value by Region (2019-2024) & (%)
    Table 44. Global Bovine Blood Plasma Derivatives Sales Value by Region (2025-2030) & (%)
    Table 45. Global Bovine Blood Plasma Derivatives Sales Volume by Region (K Liters): 2019 VS 2023 VS 2030
    Table 46. Global Bovine Blood Plasma Derivatives Sales Volume by Region (2019-2024) & (K Liters)
    Table 47. Global Bovine Blood Plasma Derivatives Sales Volume by Region (2025-2030) & (K Liters)
    Table 48. Global Bovine Blood Plasma Derivatives Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Bovine Blood Plasma Derivatives Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Bovine Blood Plasma Derivatives Average Price by Region (2019-2024) & (USD/L)
    Table 51. Global Bovine Blood Plasma Derivatives Average Price by Region (2025-2030) & (USD/L)
    Table 52. Key Countries/Regions Bovine Blood Plasma Derivatives Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Bovine Blood Plasma Derivatives Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Bovine Blood Plasma Derivatives Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Bovine Blood Plasma Derivatives Sales Volume, (2019-2024) & (K Liters)
    Table 56. Key Countries/Regions Bovine Blood Plasma Derivatives Sales Volume, (2025-2030) & (K Liters)
    Table 57. Thermo Fisher Company Information
    Table 58. Thermo Fisher Introduction and Business Overview
    Table 59. Thermo Fisher Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 60. Thermo Fisher Bovine Blood Plasma Derivatives Product Offerings
    Table 61. Thermo Fisher Recent Development
    Table 62. GE Healthcare Company Information
    Table 63. GE Healthcare Introduction and Business Overview
    Table 64. GE Healthcare Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 65. GE Healthcare Bovine Blood Plasma Derivatives Product Offerings
    Table 66. GE Healthcare Recent Development
    Table 67. Merck (Sigma-Aldrich) Company Information
    Table 68. Merck (Sigma-Aldrich) Introduction and Business Overview
    Table 69. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 70. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Product Offerings
    Table 71. Merck (Sigma-Aldrich) Recent Development
    Table 72. Moregate BioTech Company Information
    Table 73. Moregate BioTech Introduction and Business Overview
    Table 74. Moregate BioTech Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 75. Moregate BioTech Bovine Blood Plasma Derivatives Product Offerings
    Table 76. Moregate BioTech Recent Development
    Table 77. Gemini Company Information
    Table 78. Gemini Introduction and Business Overview
    Table 79. Gemini Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 80. Gemini Bovine Blood Plasma Derivatives Product Offerings
    Table 81. Gemini Recent Development
    Table 82. Atlanta Biologicals Company Information
    Table 83. Atlanta Biologicals Introduction and Business Overview
    Table 84. Atlanta Biologicals Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 85. Atlanta Biologicals Bovine Blood Plasma Derivatives Product Offerings
    Table 86. Atlanta Biologicals Recent Development
    Table 87. Tissue Culture Biologicals Company Information
    Table 88. Tissue Culture Biologicals Introduction and Business Overview
    Table 89. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 90. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Product Offerings
    Table 91. Tissue Culture Biologicals Recent Development
    Table 92. Bovogen Company Information
    Table 93. Bovogen Introduction and Business Overview
    Table 94. Bovogen Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 95. Bovogen Bovine Blood Plasma Derivatives Product Offerings
    Table 96. Bovogen Recent Development
    Table 97. Biowest Company Information
    Table 98. Biowest Introduction and Business Overview
    Table 99. Biowest Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 100. Biowest Bovine Blood Plasma Derivatives Product Offerings
    Table 101. Biowest Recent Development
    Table 102. Internegocios Company Information
    Table 103. Internegocios Introduction and Business Overview
    Table 104. Internegocios Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 105. Internegocios Bovine Blood Plasma Derivatives Product Offerings
    Table 106. Internegocios Recent Development
    Table 107. RMBIO Company Information
    Table 108. RMBIO Introduction and Business Overview
    Table 109. RMBIO Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 110. RMBIO Bovine Blood Plasma Derivatives Product Offerings
    Table 111. RMBIO Recent Development
    Table 112. Biological Industries Company Information
    Table 113. Biological Industries Introduction and Business Overview
    Table 114. Biological Industries Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 115. Biological Industries Bovine Blood Plasma Derivatives Product Offerings
    Table 116. Biological Industries Recent Development
    Table 117. VWR Company Information
    Table 118. VWR Introduction and Business Overview
    Table 119. VWR Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 120. VWR Bovine Blood Plasma Derivatives Product Offerings
    Table 121. VWR Recent Development
    Table 122. Corning Company Information
    Table 123. Corning Introduction and Business Overview
    Table 124. Corning Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 125. Corning Bovine Blood Plasma Derivatives Product Offerings
    Table 126. Corning Recent Development
    Table 127. Serana Company Information
    Table 128. Serana Introduction and Business Overview
    Table 129. Serana Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 130. Serana Bovine Blood Plasma Derivatives Product Offerings
    Table 131. Serana Recent Development
    Table 132. Lanzhou Minhai Company Information
    Table 133. Lanzhou Minhai Introduction and Business Overview
    Table 134. Lanzhou Minhai Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 135. Lanzhou Minhai Bovine Blood Plasma Derivatives Product Offerings
    Table 136. Lanzhou Minhai Recent Development
    Table 137. Zhejiang Tianhang Biotechnology Company Information
    Table 138. Zhejiang Tianhang Biotechnology Introduction and Business Overview
    Table 139. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 140. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Product Offerings
    Table 141. Zhejiang Tianhang Biotechnology Recent Development
    Table 142. ExCell Bio Company Information
    Table 143. ExCell Bio Introduction and Business Overview
    Table 144. ExCell Bio Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 145. ExCell Bio Bovine Blood Plasma Derivatives Product Offerings
    Table 146. ExCell Bio Recent Development
    Table 147. Jin Yuan Kang Company Information
    Table 148. Jin Yuan Kang Introduction and Business Overview
    Table 149. Jin Yuan Kang Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 150. Jin Yuan Kang Bovine Blood Plasma Derivatives Product Offerings
    Table 151. Jin Yuan Kang Recent Development
    Table 152. American Protein Company Company Information
    Table 153. American Protein Company Introduction and Business Overview
    Table 154. American Protein Company Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 155. American Protein Company Bovine Blood Plasma Derivatives Product Offerings
    Table 156. American Protein Company Recent Development
    Table 157. Sonac Company Information
    Table 158. Sonac Introduction and Business Overview
    Table 159. Sonac Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 160. Sonac Bovine Blood Plasma Derivatives Product Offerings
    Table 161. Sonac Recent Development
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Bovine Blood Plasma Derivatives Downstream Customers
    Table 165. Bovine Blood Plasma Derivatives Distributors List
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bovine Blood Plasma Derivatives Product Picture
    Figure 2. Global Bovine Blood Plasma Derivatives Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Bovine Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Bovine Blood Plasma Derivatives Sales Volume (2019-2030) & (K Liters)
    Figure 5. Global Bovine Blood Plasma Derivatives Sales Price (2019-2030) & (USD/L)
    Figure 6. Bovine Blood Plasma Derivatives Report Years Considered
    Figure 7. Global Bovine Blood Plasma Derivatives Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Bovine Blood Plasma Derivatives Players Sales Volume Ranking (2023) & (K Liters)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bovine Blood Plasma Derivatives Revenue in 2023
    Figure 10. Bovine Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Bovine Serum Picture
    Figure 12. FBS Picture
    Figure 13. Bovine Serum Albumin Picture
    Figure 14. Fibrinogen Picture
    Figure 15. Protein Ingredient Picture
    Figure 16. Other Picture
    Figure 17. Global Bovine Blood Plasma Derivatives Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Bovine Blood Plasma Derivatives Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Global Bovine Blood Plasma Derivatives Sales Volume by Type (2019 VS 2023 VS 2030) & (K Liters)
    Figure 20. Global Bovine Blood Plasma Derivatives Sales Volume Market Share by Type, 2023 & 2030
    Figure 21. Global Bovine Blood Plasma Derivatives Price by Type (2019-2030) & (USD/L)
    Figure 22. Product Picture of Scientific Research
    Figure 23. Product Picture of Industrial Production
    Figure 24. Product Picture of Feed
    Figure 25. Product Picture of Others
    Figure 26. Global Bovine Blood Plasma Derivatives Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 27. Global Bovine Blood Plasma Derivatives Sales Value Market Share by Application, 2023 & 2030
    Figure 28. Global Bovine Blood Plasma Derivatives Sales Volume by Application (2019 VS 2023 VS 2030) & (K Liters)
    Figure 29. Global Bovine Blood Plasma Derivatives Sales Volume Market Share by Application, 2023 & 2030
    Figure 30. Global Bovine Blood Plasma Derivatives Price by Application (2019-2030) & (USD/L)
    Figure 31. North America Bovine Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 32. North America Bovine Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    Figure 33. Europe Bovine Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 34. Europe Bovine Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    Figure 35. Asia Pacific Bovine Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Bovine Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    Figure 37. South America Bovine Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 38. South America Bovine Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    Figure 39. Middle East & Africa Bovine Blood Plasma Derivatives Sales Value (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Bovine Blood Plasma Derivatives Sales Value by Country (%), 2023 VS 2030
    Figure 41. Key Countries/Regions Bovine Blood Plasma Derivatives Sales Value (%), (2019-2030)
    Figure 42. Key Countries/Regions Bovine Blood Plasma Derivatives Sales Volume (%), (2019-2030)
    Figure 43. United States Bovine Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 44. United States Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 45. United States Bovine Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 46. Europe Bovine Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Europe Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 48. Europe Bovine Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 49. China Bovine Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 50. China Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 51. China Bovine Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 52. Japan Bovine Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Japan Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 54. Japan Bovine Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 55. South Korea Bovine Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 56. South Korea Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 57. South Korea Bovine Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 58. Southeast Asia Bovine Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 59. Southeast Asia Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 60. Southeast Asia Bovine Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 61. India Bovine Blood Plasma Derivatives Sales Value, (2019-2030) & (US$ Million)
    Figure 62. India Bovine Blood Plasma Derivatives Sales Value by Type (%), 2023 VS 2030
    Figure 63. India Bovine Blood Plasma Derivatives Sales Value by Application (%), 2023 VS 2030
    Figure 64. Bovine Blood Plasma Derivatives Industrial Chain
    Figure 65. Bovine Blood Plasma Derivatives Manufacturing Cost Structure
    Figure 66. Channels of Distribution (Direct Sales, and Distribution)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Stainless Steel Microporous Mesh - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-9Q14467
Thu May 02 00:00:00 UTC 2024

Add to Cart

Aluminum Alloy Anti-static Floor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-32K14110
Thu May 02 00:00:00 UTC 2024

Add to Cart

Add to Cart

Engineered Foam Material - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-32M13982
Thu May 02 00:00:00 UTC 2024

Add to Cart